Pre-operative Therapy in Breast Cancer
Recruiting now
Conditions studied: Breast Cancer
In brief
This is a prospective and retrospective study to evaluate the effect of pre-operative therapy on response and survival, and compare the difference in response and survival by pre-operative regimen or by patient's clinicopathological characteristic in early or advanced breast cancer.
Key facts
- Study ID
- NCT05621564
- Run by
- RenJi Hospital
- People needed
- 6032
- Starts
- 2022-11-01
- Expected to finish
- 2030-11-01
- Last updated by the study team
- 2026-08-04
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Female, Aged ≥18 years
- Histologically confirmed primary breast cancer
- Plan to receive pre-operative therapy
- Adequate organ function
You may not qualify if…
- History of neurological or psychological disease, including epilepsy or dementia
- Not suitable to participate in this study judged by investigators
Where it is running
- Renji Hospital, School of Medicine, Shanghai Jiaotong University — Shanghai, China (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.